FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics and gynaecology, can be used in programs of assisted reproductive technologies (ART) in patients with "thin" hypoplastic endometrium for increasing thickness of endometrium. At the stage of endometrial preparation for embryo implantation with underlying hormonal replacement therapy, estradiol valerate 2 mg is used once day from 5th to 25th day or estradiol in the form of hemihydrate – transdermal gel in dose of 1.5 mg twice a day. In the luteal phase from 16th to 25th day, micronized progesterone is administered orally 100 mg 2 times a day or progesterone in the form of vaginal gel 90 mg 1 time a day or dydrogesterone 10-20 mg 1 time day for 2 to 4 months. Also, the preparation "Superlimph" 25 units is used, one suppository vaginally at night for 20 days from 5th to 25th day of the menstrual cycle for 2 to 4 months to achieve endometrial thickness of more than 8 mm according to ultrasound.
EFFECT: invention provides activation of regenerative processes, promotes restoration of morphofunctional structure of endometrium, increased receptivity of endometrium, accordingly increases frequency of pregnancy and reduces risk of reproductive losses in ART programs.
1 cl, 1 dwg, 6 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RECOVERY OF ENDOMETRIUM RECEPTIVITY IN WOMEN WITH UTERINE INFERTILITY WITH THE USE OF A CAVITATED SOLUTION OF GRANULOCYTE COLONY-STIMULATING GROWTH FACTOR | 2017 |
|
RU2667611C1 |
METHOD FOR INTRAUTERINE INFUSION OF AUTOLOGOUS PLASMA OF A WOMAN TO INCREASE THE EFFECTIVENESS OF ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS | 2021 |
|
RU2762159C1 |
METHOD OF RESTORING FERTILITY IN WOMEN WITH A HISTORY OF ENDOMETRIAL INFERTILITY AGAINST THE BACKGROUND OF “THIN ENDOMETRIUM” | 2023 |
|
RU2800236C1 |
METHOD OF TREATING PATIENTS WITH INFERTILITY CAUSED BY FIBROSCLEROTICA OR HYPOPLASTIC TRANSFORMATION OF TENDOMETRIA WITH HISTORY OF REPEATED IMPLANTATION FAILURES IN ART CYCLES | 2022 |
|
RU2809667C1 |
METHOD OF TREATING FEMALE INFERTILITY, WHICH CONSISTS IN STIMULATING ENDOMETRIAL REGENERATION BY INTRAUTERINE INTRODUCTION OF PLATELET AUTOPLASMA ENRICHED WITH PLATELET GROWTH FACTORS | 2023 |
|
RU2830642C1 |
METHOD OF INCREASING EFFECTIVENESS OF AUXILIARY REPRODUCTIVE TECHNOLOGIES IN PATIENTS WITH REPEATED NON-EFFECTIVE ATTEMPTS OF IMPLANTATION | 2018 |
|
RU2669726C1 |
METHOD FOR INCREASING RECEPTIVITY OF ENDOMETRIUM IN PATIENTS WITH UTERINE INFERTILITY DUE TO ENDOMETRIAL DYSFUNCTION, IN PREPARATION FOR PROCEDURE OF IN VITRO FERTILIZATION (IVF) BY CRYOPROTOCOL | 2021 |
|
RU2746643C1 |
METHOD FOR DIAGNOSTICS OF ENDOMETRIAL IMMUNE STATUS IN PATIENTS WITH REPEATED PREGNANCY LOSS AFTER ASSISTED REPRODUCTIVE TECHNOLOGIES | 2022 |
|
RU2783849C1 |
METHOD FOR ASSESSING ENDOMETRIAL RECEPTIVENESS IN ENDOMETRIOSIS-ASSOCIATED INFERTILITY | 2020 |
|
RU2724381C1 |
METHOD FOR ASSESSING THE IMPLANTATION VIABILITY OF ENDOMETRIUM IN REPEATED IMPLANTATION FAILURES ASSOCIATED WITH CHRONIC ENDOMETRITIS | 2021 |
|
RU2746644C1 |
Authors
Dates
2025-02-25—Published
2024-09-10—Filed